These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20505312)

  • 1. CD70-driven chronic immune activation is protective against atherosclerosis.
    van Olffen RW; de Bruin AM; Vos M; Staniszewska AD; Hamann J; van Lier RA; de Vries CJ; Nolte MA
    J Innate Immun; 2010; 2(4):344-52. PubMed ID: 20505312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of CD27 in helper T cell differentiation.
    Libregts S; van Olffen RW; van der Sluijs KF; van Lier RA; Nolte MA
    Immunol Lett; 2011 May; 136(2):177-86. PubMed ID: 21277898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous CD27 triggering in vivo strongly reduces NK cell numbers.
    De Colvenaer V; Taveirne S; Hamann J; de Bruin AM; De Smedt M; Taghon T; Vandekerckhove B; Plum J; van Lier R; Leclercq G
    Eur J Immunol; 2010 Apr; 40(4):1107-17. PubMed ID: 20140903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective CD8 T cell memory is impaired during chronic CD70-driven costimulation.
    van Gisbergen KP; van Olffen RW; van Beek J; van der Sluijs KF; Arens R; Nolte MA; van Lier RA
    J Immunol; 2009 May; 182(9):5352-62. PubMed ID: 19380782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions.
    Tesselaar K; Arens R; van Schijndel GM; Baars PA; van der Valk MA; Borst J; van Oers MH; van Lier RA
    Nat Immunol; 2003 Jan; 4(1):49-54. PubMed ID: 12469117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cells produce the chemokine CXCL10 in response to CD27/CD70 costimulation to promote generation of the CD8+ effector T cell pool.
    Peperzak V; Veraar EA; Xiao Y; Babala N; Thiadens K; Brugmans M; Borst J
    J Immunol; 2013 Sep; 191(6):3025-36. PubMed ID: 23940275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity.
    Keller AM; Schildknecht A; Xiao Y; van den Broek M; Borst J
    Immunity; 2008 Dec; 29(6):934-46. PubMed ID: 19062317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology.
    Nolte MA; van Olffen RW; van Gisbergen KP; van Lier RA
    Immunol Rev; 2009 May; 229(1):216-31. PubMed ID: 19426224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
    Merched AJ; Chan L
    Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.
    Caligiuri G; Nicoletti A; Poirier B; Hansson GK
    J Clin Invest; 2002 Mar; 109(6):745-53. PubMed ID: 11901183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD27 and CD70 in T cell and B cell activation.
    Borst J; Hendriks J; Xiao Y
    Curr Opin Immunol; 2005 Jun; 17(3):275-81. PubMed ID: 15886117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation.
    Arens R; Schepers K; Nolte MA; van Oosterwijk MF; van Lier RA; Schumacher TN; van Oers MH
    J Exp Med; 2004 Jun; 199(11):1595-605. PubMed ID: 15184507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of lymphocyte function through CD27-CD70 interactions.
    Lens SM; Tesselaar K; van Oers MH; van Lier RA
    Semin Immunol; 1998 Dec; 10(6):491-9. PubMed ID: 9826582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans.
    Hashimoto-Okada M; Kitawaki T; Kadowaki N; Iwata S; Morimoto C; Hori T; Uchiyama T
    Int Immunol; 2009 Aug; 21(8):891-904. PubMed ID: 19556308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune activation modulates hematopoiesis through interactions between CD27 and CD70.
    Nolte MA; Arens R; van Os R; van Oosterwijk M; Hooibrink B; van Lier RA; van Oers MH
    Nat Immunol; 2005 Apr; 6(4):412-8. PubMed ID: 15723067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
    Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
    Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs.
    Burchill MA; Tamburini BA; Kedl RM
    Eur J Immunol; 2015 Nov; 45(11):3140-9. PubMed ID: 26179759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation.
    Hintzen RQ; Lens SM; Lammers K; Kuiper H; Beckmann MP; van Lier RA
    J Immunol; 1995 Mar; 154(6):2612-23. PubMed ID: 7876536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
    Jeon HJ; Choi JH; Jung IH; Park JG; Lee MR; Lee MN; Kim B; Yoo JY; Jeong SJ; Kim DY; Park JE; Park HY; Kwack K; Choi BK; Kwon BS; Oh GT
    Circulation; 2010 Mar; 121(9):1124-33. PubMed ID: 20176988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.